Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "CROs"

4243 News Found

DENSTAR project launched to fast-track dengue vaccine licensure in Africa
Healthcare | June 09, 2026

DENSTAR project launched to fast-track dengue vaccine licensure in Africa

Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa


Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles
People | June 09, 2026

Merck appoints Clara Sattler de Sousa e Brito and Robert Machinek to key leadership roles

Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development


Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain
News | June 09, 2026

Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain

Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care


FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion
News | June 09, 2026

FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion

Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California


Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide
News | June 09, 2026

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide

The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format


AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial
Clinical Trials | June 09, 2026

AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial

At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint


Group Mangalam enters India’s wellness market with launch of Neat Everyday
Healthcare | June 09, 2026

Group Mangalam enters India’s wellness market with launch of Neat Everyday

The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand


FUJIFILM brings next-gen AI-enabled digital mammography platform to India
Medical Device | June 09, 2026

FUJIFILM brings next-gen AI-enabled digital mammography platform to India

First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection


Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial
News | June 09, 2026

Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial

Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter


Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours
Healthcare | June 09, 2026

Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours

Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology